Výsledky vyhledávání

Dietary Beta-1,3/1,6-Glucans Reduce Clinical Signs of Canine Atopy

Autor: J. Middelkoop, A. C. Beynen, F. V. Altena, P. M. Paap, E. A. Visser, L. D. Jong, M. Staats, D. H.J. Saris

Publikováno v: American Journal of Animal and Veterinary Sciences. 6:146-152

Problem statement: There was evidence that beta-1,3/1,6-glucans modulate inflammatory activity. In an open, non-controlled trial, purified beta-1,3/1,6-glucans were found to improve the clinical signs of dogs with undefined chronic skin disorders. Gi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::be6fb7b1ba43984e71f14630e8c0ed07
https://doi.org/10.3844/ajavsp.2011.146.152

Zobrazit plný text záznamu

Standardization and characterization of ATIR cell therapy product: applying QbD to both process and assay development

Autor: L. d. Jong, Denis-Claude Roy, M. Ruediger, R. Preti, J. Darwiche, J. Velthuis, M. Corrieveau

Publikováno v: Cytotherapy. 16:S24

Kiadis Pharma is developing ATIR, a T-cell immunotherapy based on a donor lymphocyte preparation selectively depleted of host alloreactive T-cells to reduce risks and improve outcomes of haploidentical stem cell transplantation for blood cancer patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71c42f339fbce6c35363538fbf61b48d
https://doi.org/10.1016/j.jcyt.2014.01.073

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání